Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Enlace a Imágenes BROOKLYN, N.Y., April 15, 2026 (GLOBE NEWSWIRE) -- Hispanic Information and Telecommunication Network, Inc. (HITN), una organización estadounidense sin fines de lucro dedicada a...
-
Edye marks its 7th year as the leading Spanish-language preschool content platform for U.S. Hispanics and Latin America: safe, pedagogical, and joyful.
-
Dime Announces Significant Hires to Advance Growth Plan
-
HINGHAM, Mass., April 14, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it will...
-
Shareholder Notice: BellRing Brands (NYSE: BRBR); Coty (NYSE: COTY); e.l.f. Beauty (NYSE: ELF); and Power Solutions International (NASDAQ: PSIX)
-
HINGHAM, Mass., April 13, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced today that it has...
-
Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly...
-
Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants L'approbation dans l'urticaire chronique spontanée...
-
Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria Approval in CSU for children two to 11 years of age is...
-
Notice ASP Isotopes Inc, (NASDAQ: ASPI); BellRing Brands, Inc. (NYSE: BRBR); Coty Inc. (NYSE: COTY); and Power Solutions International, Inc. (NASDAQ: PSIX)